Mgr. Karla Plevová, Ph.D.
Head of the research group, Karla Plevová Research Group: Genomics of Immune Cells
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Office: bldg. E35/258
Kamenice 753/5
625 00 Brno
Phone: | +420 532 23 4396 |
---|---|
E‑mail: | |
Web: | https://genomika.med.muni.cz/research/research-groups/karla-plevova-group/about-us |
social and academic networks: |
---|
Total number of publications: 357
2015
-
ATM mutations in major stereotyped CLL subsets: enrichment in subset #2 is associated with unfavourable outcome
Year: 2015, type: Conference abstract
-
CLL with mutated IGHV4-34 antigen receptors is clinically heterogeneous: Antigen receptor stereotypy makes the difference.
Year: 2015, type: Conference abstract
-
COBLL1 as a survival predictor in chronic lymphocytic leukaemia patients.
Year: 2015, type: Conference abstract
-
Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia
Leukemia, year: 2015, volume: 29, edition: 4, DOI
-
Dissecting resistence mechanisms in chronic lymphocytic leukemia using whole-exome sequencing: impact of recurrent RPS15 mutations on p53 dysregulation.
Year: 2015, type: Conference abstract
-
Functional loss of I kappa B epsilon leads to NF-kappa B deregulation in aggressive chronic lymphocytic leukemia
The Journal of Experimental Medicine, year: 2015, volume: 212, edition: 6, DOI
-
Higher-order immunoglobulin sequence relations for major subsets of chronic lymophocytic leukemia: uniqueness versus equivalence
Year: 2015, type: Conference abstract
-
Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method
Publisher: United States Patents and Trademark, state: United States of America, patent's number: US 9,057,106, year: 2015
-
MicroRNA involvement in DNA damage response and BCR signaling in malignant B cells
Year: 2015, type: Conference abstract
-
Mutations in the TP53 gene show feature sof somatic hypermutation process with prominent diference between IGHV mutated and unmutated chronci lymphocytic leukemia
Year: 2015, type: Conference abstract